Literature DB >> 2125704

Oestrogen modulation of excitatory A1 noradrenergic input to rat medial preoptic gamma aminobutyric acid neurones demonstrated by microdialysis.

A E Herbison1, R P Heavens, R G Dyer.   

Abstract

The effect of A1 cell group electrical stimulation on the simultaneous release of endogenous noradrenaline (NA) and gamma-aminobutyric acid (GABA) from the medial preoptic area (MPOA) was monitored with microdialysis. In ovariectomised (OVX) rats a 15-min period of A1 stimulation induced an immediate increase in both NA and GABA release in the MPOA. Electrical stimulation lateral to the A1 region did not alter NA or GABA release. The addition of the alpha-adrenergic antagonist phenoxybenzamine to the perfusion medium resulted in a significant increase in basal NA levels, and electrical stimulation during this period further increased NA release while GABA levels were not significantly altered throughout. The effect of oestrogen on this pathway was examined in animals at a time of oestrogen-negative feedback on luteinising hormone (LH) secretion (OVX-EBn) and prior to the expected oestrogen-induced LH surge (OVX-EBp). Activation of A1 neurones in OVX-EBn rats resulted in NA and GABA increases in the MPOA similar to that observed with OVX rats. In OVX-EBp animals, basal GABA levels were found to be significantly higher compared with OVX rats but NA release induced by A1 stimulation had no effect on GABA levels. Depolarisation of the MPOA by increasing the potassium ion concentration of the perfusion medium evoked significantly greater GABA release from OVX-EBp rats compared with the OVX and OVX-EBn animals. Potassium-stimulated NA release was not significantly altered by oestrogen administration. These results demonstrate an excitatory alpha-adrenergic mediated noradrenergic input to GABA neurones in the MPOA.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125704     DOI: 10.1159/000125568

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  7 in total

1.  Effects of noradrenergic alpha-2 receptor antagonism or noradrenergic lesions in the ventral bed nucleus of the stria terminalis and medial preoptic area on maternal care in female rats.

Authors:  Carl D Smith; M Allie Holschbach; Joshua Olsewicz; Joseph S Lonstein
Journal:  Psychopharmacology (Berl)       Date:  2012-05-29       Impact factor: 4.530

2.  Effects of gamma-aminobutyric acid receptor agonists and antagonist on LHRH-synthesizing neurons as detected by immunocytochemistry and in situ hybridization.

Authors:  H T Bergen; J F Hejtmancik; D W Pfaff
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

3.  Role of medial preoptic GABA neurones in regulating luteinising hormone secretion in the ovariectomised rat.

Authors:  A E Herbison; C Chapman; R G Dyer
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

Review 4.  Chapter 2: hypothalamic neural systems controlling the female reproductive life cycle gonadotropin-releasing hormone, glutamate, and GABA.

Authors:  Jacqueline A Maffucci; Andrea C Gore
Journal:  Int Rev Cell Mol Biol       Date:  2009       Impact factor: 6.813

5.  Reduced Hippocampal GABA+ Is Associated With Poorer Episodic Memory in Healthy Older Women: A Pilot Study.

Authors:  Joan Jiménez-Balado; Alexandra Ycaza Herrera; Kay Igwe; Lynda Klem; Korhan Buyukturkoglu; Andrei Irimia; Liu Chen; Jia Guo; Adam M Brickman; Teal S Eich
Journal:  Front Behav Neurosci       Date:  2021-08-26       Impact factor: 3.558

6.  Sex- and age-related changes in GABA signaling components in the human cortex.

Authors:  Madhavi Pandya; Thulani H Palpagama; Clinton Turner; Henry J Waldvogel; Richard L Faull; Andrea Kwakowsky
Journal:  Biol Sex Differ       Date:  2019-01-14       Impact factor: 5.027

Review 7.  GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer's disease.

Authors:  Joan Jiménez-Balado; Teal S Eich
Journal:  Semin Cell Dev Biol       Date:  2021-02-09       Impact factor: 7.727

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.